.While the biotech assets performance in Europe has slowed down relatively following a COVID-19 back...
.After bring up $213 thousand in 2023-- among the year's most extensive private biotech rounds-- Vol...
.Accept to this week's Chutes & Ladders, our roundup of significant management hirings, shootings...
.Equity capital funding in to biopharma rose to $9.2 billion across 215 deals in the second one-four...
.Bicara Therapeutics as well as Zenas Biopharma have provided clean motivation to the IPO market wit...
.Genentech is going to close its cancer immunology investigation team, and device head as well as we...
.Kezar Life Sciences is dropping its unpromising period 1 sound cyst medicine as the biotech goes al...
.In spite of izokibep sustaining its own newly found winning touch in the clinic, Acelyrin is no lon...
.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing drug applicant, m...
.Ovid Therapy already exposed last month that it was trimming its headcount as the firm gets through...